{"title":"生物技术:转型中的全球产业的结构、挑战与机遇","authors":"G. Burrill","doi":"10.5172/IMPP.1998.1.4.3","DOIUrl":null,"url":null,"abstract":"G. Steven Burrill has been involved in biotechnology since it first spawned an 'industry'. A member of the board of several biotechnology companies and internationally recognized industry advisor, he now heads up a San Francisco-based life-sciences focused merchant bank with its own venture capital investment fund. This article provides an expert's overview of the structure of the biotechnology industry and the hurdles and rewards that may be encountered in investing in it.","PeriodicalId":13564,"journal":{"name":"Innovation-management Policy & Practice","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Biotechnology: Structure, challenges, and opportunities of a global industry in transition\",\"authors\":\"G. Burrill\",\"doi\":\"10.5172/IMPP.1998.1.4.3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"G. Steven Burrill has been involved in biotechnology since it first spawned an 'industry'. A member of the board of several biotechnology companies and internationally recognized industry advisor, he now heads up a San Francisco-based life-sciences focused merchant bank with its own venture capital investment fund. This article provides an expert's overview of the structure of the biotechnology industry and the hurdles and rewards that may be encountered in investing in it.\",\"PeriodicalId\":13564,\"journal\":{\"name\":\"Innovation-management Policy & Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Innovation-management Policy & Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5172/IMPP.1998.1.4.3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovation-management Policy & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5172/IMPP.1998.1.4.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
G. Steven Burrill从生物技术第一次产生一个“产业”开始就参与其中。作为几家生物技术公司的董事会成员和国际公认的行业顾问，他现在领导着一家总部位于旧金山的专注于生命科学的商业银行，该银行拥有自己的风险投资基金。这篇文章提供了一个专家对生物技术产业结构的概述，以及投资它可能遇到的障碍和回报。
Biotechnology: Structure, challenges, and opportunities of a global industry in transition
G. Steven Burrill has been involved in biotechnology since it first spawned an 'industry'. A member of the board of several biotechnology companies and internationally recognized industry advisor, he now heads up a San Francisco-based life-sciences focused merchant bank with its own venture capital investment fund. This article provides an expert's overview of the structure of the biotechnology industry and the hurdles and rewards that may be encountered in investing in it.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
